Hormonal regulation of gastric acid secretion

Current Gastroenterology Reports

Volumn 10, Issue 6, 2008, Pages 523-527

  Schubert, Mitchell L ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CHOLECYSTOKININ; CYANOCOBALAMIN; ENTEROGASTRONE; GASTRIN; GASTROINTESTINAL HORMONE; GHRELIN; GLUCAGON LIKE PEPTIDE; GLUCAGON LIKE PEPTIDE 1; HISTAMINE; IRON; LIPID; NEUROTENSIN; OMEPRAZOLE; OREXIN; OREXIN A; OREXIN B; PROTEIN; PROTON PUMP INHIBITOR; SECRETIN; THYROXINE; UNCLASSIFIED DRUG;

BACTERIAL OVERGROWTH; CALCIUM ABSORPTION; DIGESTIVE SYSTEM FUNCTION DISORDER; DRUG MECHANISM; DRUG WITHDRAWAL; ENTEROCHROMAFFIN CELL; FUNCTIONAL ANATOMY; HELICOBACTER INFECTION; HISTAMINE RELEASE; HORMONAL REGULATION; HORMONE ACTION; HUMAN; INTESTINE INFECTION; IRON ABSORPTION; MUCOSAL IMMUNITY; NEUROMODULATION; NONHUMAN; PARACRINE SIGNALING; PROTEIN METABOLISM; REVIEW; STOMACH ACID SECRETION; STOMACH ULCER; THYROXINE METABOLISM; VITAMIN METABOLISM;

ANIMALS; GASTRIC ACID; GASTRINS; GASTROINTESTINAL HORMONES; GHRELIN; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEUROPEPTIDES; STOMACH;

EID: 60749105533     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-008-0097-5     Document Type: Review

References (43)

1. Checchi S, Montanaro A, Pasqui L, et al.: L-thyroxine requirement in patients with autoimmune hypothyroidism and parietal cell antibodies. J Clin Endocrinol Metab 2008, 93: 465-469.
2. Dimaline R, Varro A: Attack and defence in the gastric epithelium - a delicate balance. Exp Physiol 2007, 92: 591-601.
3. Joseph IMP, Zavros Y, Merchant JL, Kirschner D: A model for integrative study of human gastric acid secretion. J Appl Physiol 2003, 94: 1602-1618.
4. Schubert ML, Peura DA: Control of gastric acid secretion in health and disease. Gastroenterology 2008, 134: 1842-1860.
5. Marco E, Foucaud M, Langer I, et al.: Mechanism of activation of a G protein-coupled receptor, the human cholecystokinin-2 receptor. J Biol Chem 2007, 282: 28779-28790.
6. Foucaud M, Archer-Lahlou E, Marco E, et al.: Insights into the binding and activation sites of the receptors for cholecystokinin and gastrin. Regul Pept 2008, 145: 17-23.
7. Cui G, Waldum HL: Physiological and clinical significance of enterochromaffin-like cell activation in the regulation of gastric acid secretion. World J Gastroenterol 2007, 28: 493-496.
8. Friis-Hansen L, Schjerling CK, de la Cour CD, et al.: Characteristics of gastrin controlled ECL cell specific gene expression. Regul Pept 2007, 140: 153-161.
9. Fykse V, Solligard E, Bendheim M, et al.: ECL cell histamine mobilization and parietal cell stimulation in the rat stomach studied by microdialysis and electron microscopy. Acta Physiol 2006, 186: 37-43.
10. Vuyyuru L, Schubert ML: Histamine, acting via H3 receptors, inhibits somatostatin and stimulates acid secretion in isolated mouse stomach. Gastroenterology 1997, 113: 1545-1552.
11. Vuyyuru L, Harrington L, Arimura A, Schubert ML: Reciprocal inhibitory paracrine pathways link histamine and somatostatin secretion in the fundus of the stomach. Am J Physiol Gastrointest Liver Physiol 1997, 273: G106-G111.
12. Chen D, Aihara T, Zhao C-M, et al.: Differentiation of the gastic mucosa. I. Role of histamine in control of function and integrity of oxyntic mucosa: Understanding gastric physiology through disruption of targeted genes. Am J Physiol Gastrointest Liver Physiol 2006, 291: G539-G544.
13. Lindström E, Chen D, Norlén P, et al.: Control of gastric acid secretion: The gastrin-ECL cell-parietal cell axis. Comp Biochem Physiol A 2001, 128: 505-514.
14. Manela FD, Ren J, Gao J, et al.: Calcitonin gene-related peptide modulates acid-mediated regulation of somatostatin and gastrin release from rat antrum. Gastroenterology 1995, 109: 701-706.
15. Schubert ML, Jong MJ, Makhlouf GM: Bombesin/GRPstimulated somatostatin secretion is mediated by gastrin in the antrum and intrinsic neurons in the fundus. Am J Physiol Gastrointest Liver Physiol 1991, 261: G885-G889.
16. Gillen D, Wirz A, McColl KEL: Helicobacter pylori eradication releases prolonged increased acid secretion following omeprazole treatment. Gastroenterology 2004, 126: 980-988.
17. DeBlock CEM, DeLeeuw IH, VanGaal LF: Autoimmune gastritis in type 1 diabetes: A clinically oriented review. J Clin Endocrinol Metab 2008, 93: 363-371.
18. Hou W, Schubert ML: Treatment of gastric carcinoids. Curr Treat Options Gastroenterol 2007, 10: 123-133.
19. Anlauf M, Perren A, Kloppel G: Endocrine precursor lesions and microadenomas of the duodenum and pancreas with and without MEN1: Criteria, molecular concepts and clinical significance. Pathobiology 2007, 74: 279-284.
20. Berna MJ, Annibale B, Marignani M, et al.: A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factors. J Clin Endocrinol Metab 2008, 93: 1582-1591.
21. Kojima M: The discovery of ghrelin - a personal memory. Regul Pept 2008, 145: 2-6.
22. Zhao CM, Furnes MW, Stenstrom B, et al.: Characterization of obestatin-and ghrelin-producing cells in the gastrointestinal tract and pancreas of rats: An immunohistochemical and electron-microscopic study. Cell Tissue Res 2008, 331: 575-587.
23. Sonmez MF, Ozan E: Determination of ghrelin immunoreactivity in the rat stomach after fasting and refeeding. Acta Histochem 2007, 109: 193-199.
24. Lin E, Gletsu N, Fugate K, et al.: The effects of gastric surgery on systemic ghrelin levels in the morbidly obese. Arch Surg 2004, 139: 780-784.
25. Levin F, Edholm T, Ehrstrom M, et al.: Effect of peripherally administered ghrelin on gastric emptying and acid secretion in the rat. Regul Pept 2005, 131: 59-65.
26. Wang L, Basa NR, Shaikh A, et al.: LPS inhibits fasted plasma ghrelin levels in rats: Role of IL-1 and PGs and functional implications. Am J Physiol Gastrointest Liver Physiol 2006, 291: G611-G620.
27. Luque RM, Gahete MD, Hochgeschwender U, Kineman RD: Evidence that endogenous SST inhibits ACTH and ghrelin expression by independent pathways. Am J Physiol Endocrinol Metab 2006, 291: E395-E403.
28. Isomoto H, Nakazato M, Ueno H, et al.: Low plasma ghrelin levels in patients with Helicobacter pylori associated gastritis. Am J Med 2004, 117: 429-432.
29. Yakabi K, Ro S, Onouhi T, et al.: Histamine mediates the stimulatory action of ghrelin on acid secretion in rat stomach. Dig Dis Sci 2006, 51: 1313-1321.
30. Heinonen MV, Purhonen AK, Makela KA, Herzig KH: Functions of orexins in peripheral tissues. Acta Physiol 2008, 192: 471-485.
31. Ehrström M, Gustafsson T, Finn A, et al.: Inhibitory effect of exogenous orexin a on gastric emptying, plasma leptin, and the distribution of orexin and orexin receptors in the gut and pancreas in man. J Clin Endocrinol Metab 2005, 90: 2370-2377.
32. Ehrström M, Levin F, Kirchgessner AL, et al.: Stimulatory effect of endogenous orexin A on gastric emptying and acid secretion independent of gastrin. Regul Pept 2005, 132: 9-16.
33. Lloyd KCK, Amirmoazzami S, Friedik F, et al.: Candidate canine enterogastrones: Acid inhibition before and after vagotomy. Am J Physiol Gastrointest Liver Physiol 1997, 272: G1236-G1242.
34. Beales ILP, Calam J: Truncated glucagon-like peptide-1 and oxyntomodulin stimulate somatostatin release from rabbit fundic D-cells in primary culture. Exp Physiol 1996, 81: 1039-1041.
35. DelValle J, Wakasugi J, Takeda H, Yamada T: Linkage of [Ca2+]i in single isolated D cells to somatostatin secretion induced by cholecystokinin. Am J Physiol Gastrointest Liver Physiol 1996, 270: G897-G901.
36. Wettergren A, Wojdemann M, Meisner S, et al.: The inhibitory effect of glucagon-like peptide-1 (GLP-1) 7-36 amide on gastric acid secretion in humans depends on an intact vagal innervation. Gut 1997, 40: 597-601.
37. Rossowski WJ, Cheng BL, Jiang NY, Coy DH: Examination of somatostatin involvement in the inhibitory action of GIP, GLP-1, amylin and adrenomedullin on gastric acid release using a new SRIF antagonist analogue. Br J Pharmacol 1998, 125: 1081-1087.
38. Fung LC, Chisholm C, Greenberg GR: Glucagon-like peptide-1-(7-36) amide and peptide YY mediate intraduodenal fat-induced inhibition of acid secretion in dogs. Endocrinology 1998, 139: 189-194.
39. Whited KL, Thao D, Lloyd KCK, et al.: Targeted disruption of the murine CCK1 receptor gene reduces intestinal lipidinduced feedback inhibition of gastric function. Am J Physiol Gastrointest Liver Physiol 2006, 291: G156-G162.
40. Zhao XT, Walsh JH, Wong H, et al.: Intestinal fat-induced inhibition of meal-stimulated gastric acid secretion depends on CCK but not peptide YY. Am J Physiol Gastrointest Liver Physiol 1999, 276: G550-G555.
41. Chey WY, Kim MS, Lee KY, Chang TM: Secretin is an enterogastrone in the dog. Am J Physiol Gastrointest Liver Physiol 1981, 240: G239-G244.
42. Seal A, Liu E, Buchan A, Brown J: Immunoneutralization of somatostatin and neurotensin: Effect on gastric acid secretion. Am J Physiol Gastrointest Liver Physiol 1988, 255: G40-G45.
43. Larsen PJ, Holst JJ: Glucagon-Helated peptide 1 (GLP-1): hormone and neurotransmitter. Regul Pept 2005, 128: 97-107.